Chapter 01 · Overview

Overview as a reviewable surface.

The overview defines the boundary of Clinical Trials & Evidence Generation: what belongs in scope, what remains outside the claim, and what evidence has to travel with any public or operational interpretation.

Focus: trial evidence · GCP · recordsRisk: untraceable influenceBridge: protocol · data · decision record
Clinical Trials traceProtocolSiteDataSafetyAnalysisRecordAIsystemsource to workflow to evidence to review
/ 01

Overview chapter.

Clinical Trials

The overview defines the boundary of Clinical Trials & Evidence Generation: what belongs in scope, what remains outside the claim, and what evidence has to travel with any public or operational interpretation.

/ A

What this page maps.

operating content
Scope boundary

Scope boundary

Names the healthcare workflows and decisions this workspace reads, while keeping clinical, legal, and product-specific claims separate.

Operating map

Operating map

Connects Clinical Trials signals to users, records, controls, and review points.

iFeed use

iFeed use

Turns broad AI movement into source-backed questions that can support learning, outreach, checklist design, and consulting conversations.

/ B

Governance questions.

review logic
Question

What decision or record does this overview surface influence, and who owns that decision?

Question

Which evidence is needed before routine use in Clinical Trials, and where is it retained?

Question

What signal triggers review, restriction, escalation, or retirement?

/ evidence

Evidence-ready minimum record.

iFeed use
Minimum record
OwnerNamed operational, clinical, technical, and governance owners.
UseClear intended use, user group, workflow point, and excluded use.
RiskRisk tier, rationale, residual risks, controls, and escalation route.
EvidenceSource claims, validation basis, limitations, approval decision, and review date.
/ sources

Source anchors and claim boundary.

official first

These anchors support the source layer for this page. iFeed interpretation remains separate from source facts and does not replace legal, regulatory, clinical, or product-specific advice.